ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Savolitinib found to help treatment-resistant lung cancer in combo with AZ’s Tagrisso
April 04, 2019The addition of ChiMed’s c-MET inhibitor savolitinib to AstraZeneca’s Tagrisso (osimertinib) has been found to help patients with EGFR-mutant non-small-cell lung cancer (NSCLC) that had developed resistance to prior EGFR-targeted therapies through MET-gen
Pharma Sources Insight January 2025
